23andMe Gets Some Insurer Claims Paused In DNA Test Row
A California federal judge said Thursday that consumer genetic testing company 23andMe can delay facing an insurer's claims that it shouldn't cover damages from off-label marketing and wrongful acts, because those...To view the full article, register now.
Already a subscriber? Click here to view full article